ahlam1399
08-20-2015, 03:42 AM
?Female Viagra? seen more a pace-setter than moneymaker
(Reuters) - The first U.S. treatment for low ***ual desire in women, dubbed “female Viagra,” is more likely to help build a market for better future rival ***** than achieve the sales seen for Pfizer Inc’s famous little blue pill for men, industry experts said.
http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/1/rc.img (http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/1/rc.htm)
http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/2/rc.img (http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/2/rc.htm)
http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/3/rc.img (http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/3/rc.htm)
http://da.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2.img (http://da.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2.htm)
http://adchoice.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/ach.img (http://adchoice.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/ach.htm)http://pi.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2t.imghttp://pi2.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4920438b/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=-zFX0oAUBZE:2Cx0SeoQB9o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-zFX0oAUBZE:2Cx0SeoQB9o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=-zFX0oAUBZE:2Cx0SeoQB9o:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-zFX0oAUBZE:2Cx0SeoQB9o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=-zFX0oAUBZE:2Cx0SeoQB9o:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/-zFX0oAUBZE
(Reuters) - The first U.S. treatment for low ***ual desire in women, dubbed “female Viagra,” is more likely to help build a market for better future rival ***** than achieve the sales seen for Pfizer Inc’s famous little blue pill for men, industry experts said.
http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/1/rc.img (http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/1/rc.htm)
http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/2/rc.img (http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/2/rc.htm)
http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/3/rc.img (http://rc.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/rc/3/rc.htm)
http://da.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2.img (http://da.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2.htm)
http://adchoice.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/ach.img (http://adchoice.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/ach.htm)http://pi.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2t.imghttp://pi2.feedsportal.com/r/234567509721/u/49/f/654207/c/35217/s/4920438b/sc/24/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4920438b/sc/24/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=-zFX0oAUBZE:2Cx0SeoQB9o:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-zFX0oAUBZE:2Cx0SeoQB9o:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=-zFX0oAUBZE:2Cx0SeoQB9o:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=-zFX0oAUBZE:2Cx0SeoQB9o:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=-zFX0oAUBZE:2Cx0SeoQB9o:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/-zFX0oAUBZE